FORM OF CONTINGENT VALUE RIGHTS AGREEMENTRights Agreement • May 29th, 2020 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [ ], 2020 (this “Agreement”), is entered into by and between AcelRx Pharmaceuticals, Inc., a Delaware corporation (“Parent”), and Computershare Inc., a Delaware corporation, as Rights Agent (the “Rights Agent”).
AMENDMENT NO. 1 TO CO-PROMOTION AGREEMENTCo-Promotion Agreement • May 29th, 2020 • Acelrx Pharmaceuticals Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 1 (the “Amendment”) TO THE CO-PROMOTION AGREEMENT DATED MARCH 15, 2020 (the “Agreement”) is entered into as of May 26, 2020 by and between ACELRX PHARMACEUTICALS, INC., a Delaware corporation, having an address of 351 Galveston Drive, Redwood City, California 94063 (hereinafter referred to as “AcelRx”), and TETRAPHASE PHARMACEUTICALS, INC., a Delaware corporation, having an address of 480 Arsenal Way, Suite 100, Watertown, Massachusetts 02472 (hereinafter referred to as “Tetraphase”). AcelRx and Tetraphase are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
